Optimizing pain control during the opioid epidemic

CM Harbaugh, PA Suwanabol - Surgical Clinics, 2019 - surgical.theclinics.com
More than 100 million Americans experience chronic daily pain. 1 Moreover, it is estimated
that more than 65.9 million outpatient surgical procedures are performed in the United …

Endogenous opiates and behavior: 2018

RJ Bodnar - Peptides, 2020 - Elsevier
This paper is the forty-first consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Disparities in opioid pain management for long bone fractures

AC Benzing, C Bell, M Derazin, R Mack… - Journal of Racial and …, 2020 - Springer
An expanding body of evidence has established that racial disparities exist in the US
healthcare system, manifesting in poorer health outcomes for members of the non-white …

How do opioid prescribing restrictions affect pharmaceutical promotion? lessons from the mandatory access prescription drug monitoring programs

TD Nguyen, WD Bradford, KI Simon - 2019 - nber.org
Prior work considers effects of prescribing restrictions on opioid use but not upstream
implications for pharmaceutical marketing activities, despite the inordinate role many believe …

Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences

AR Brown, JE Walters, B Harmer, L Cates… - Journal of Substance Use …, 2023 - Elsevier
Abstract Introduction The United States has experienced substantial increases in opioid use
for more than two decades. This growth has impacted rural areas where overdoses have …

Patterns of opioid analgesic use in the US, 2009 to 2018

C Woods, G Chai, T Meyer, J Staffa, G Dal Pan - Pain, 2021 - journals.lww.com
Although overall outpatient dispensing of opioid analgesic prescriptions has declined, there
may still be overprescribing. Understanding how many opioid analgesic units, primarily …

Key evidence supporting prescription opioids approved by the US Food and Drug Administration, 1997 to 2018

J Heyward, TJ Moore, J Chen, K Meek… - Annals of internal …, 2020 - acpjournals.org
Background: Little is known about the evidence required by the US Food and Drug
Administration (FDA) for new approvals of opioid analgesics. Objective: To characterize the …

The “nuts and bolts” of opioid marketing: Promotional messages to family doctors in Sacramento, Vancouver, Montreal, and Toulouse

B Mintzes, J Lexchin - Journal of General Internal Medicine, 2020 - Springer
METHODS We recruited random samples of primary care physicians in Sacramento,
Vancouver, Montreal, and Toulouse (n= 255) to report on consecutive sales visits …

Cost of Constipation: A New Look With a Focus on New Medications

K Bielefeldt - Journal of Clinical Gastroenterology, 2022 - journals.lww.com
Background: Secretagogues have been introduced as new agents for the treatment of
constipation. Previously published modeling studies suggested that improved productivity …

Hepatitis C infection screening and management in opioid use epidemics in the United States

X Liu, J Shen, P Kim, S Park, S Chun, JJ Pan… - The American Journal …, 2018 - amjmed.com
Acute hepatitis C infection is on the rise in the United States, with a more than twofold
increase in incidence rate from 2003 to 2016 overall and a threefold increase among young …